Skip to content

Insider · CIK 0001610732

John Greene

cfoofficerdirector

Files at DFS (Discover Financial Services), CRSP (CRISPR Therapeutics AG). First filing Feb 28, 2025, latest Feb 28, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$314k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CRSP: CRISPR Therapeutics AG

CRSPOct 9, 2026 · close 53.39

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
37Weak
CRSPbuy
CRISPR Therapeutics AG
$314k
7,000 shares
--

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 5, 2025CRSP
CRISPR Therapeutics AG
AGrant or award
Stock Option (Right to Buy)derivative
+13,000$0.00$013,000Jun 6, 2025
May 18, 2025DFS
Discover Financial Services
DDisposition to issuer
Common Stock
-79,943--0May 19, 2025
Feb 26, 2025CRSP
CRISPR Therapeutics AG
POpen-market purchase
Common Shares
+7,000$44.85$314k7,000Feb 28, 2025
Feb 1, 2025DFS
Discover Financial Services
FTax withholding
Common Stock
-1,840$201.09$370k79,866Feb 4, 2025
Jan 23, 2025DFS
Discover Financial Services
AGrant or award
Common Stock
+14,630$0.00$081,706Jan 27, 2025
Dec 19, 2024DFS
Discover Financial Services
AGrant or award
Common Stock
+12,109$0.00$078,778Dec 23, 2024
Dec 19, 2024DFS
Discover Financial Services
FTax withholding
Common Stock
-11,702$169.27$2.0M67,076Dec 23, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

John Greene: insider trades and track record | InsiderTell